Literature DB >> 18845363

[Tuberculosis in France: new challenges for practitioners].

D Che1, N Lefebvre, F Antoun, P Fraisse, M Depinoy, D Antoine, D Farge, M-C Paty.   

Abstract

The need for a national tuberculosis control program was based on disparities of incidence by geographical area or by population group, and differences in tuberculosis control practice. This program was developed within the context of the 2004 public health act that prioritised tuberculosis control with the objective "to stabilise the tuberculosis incidence by reinforcing control strategies in groups and zones at risk". The tuberculosis control programme, launched in July 2007, aims to consolidate the decrease of the tuberculosis incidence and to reduce the inequalities. This implies, in particular, reaching the most exposed populations, to ensure an adequate management of cases with a good treatment observance. This also implies preventing transmission in health care settings, and maintaining the low level of multiresistance and must be done despite the loss of expertise due to a decrease in incidence. The six major objectives of the tuberculosis control program are to ensure an early diagnosis and an adequate treatment for all tuberculosis cases, to improve screening, to optimise the BCG policy, to maintain antituberculosis resistance at a low level, to improve the epidemiological surveillance and the knowledge of the determinants of tuberculosis and to improve the management of tuberculosis control activities.

Entities:  

Mesh:

Year:  2008        PMID: 18845363     DOI: 10.1016/j.revmed.2008.07.014

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  3 in total

1.  Evaluation of the tuberculin skin test and the interferon-gamma release assay for TB screening in French healthcare workers.

Authors:  Dominique Tripodi; Benedicte Brunet-Courtois; Virginie Nael; Marie Audrain; Edmond Chailleux; Patrick Germaud; Frederique Naudin; Jean-Yves Muller; Martine Bourrut-Lacouture; Marie-Henriette Durand-Perdriel; Claire Gordeeff; Guyonne Guillaumin; Marietherese Houdebine; Francois Raffi; David Boutoille; Charlotte Biron; Gilles Potel; Claude Roedlich; Christian Geraut; Anja Schablon; Albert Nienhaus
Journal:  J Occup Med Toxicol       Date:  2009-11-30       Impact factor: 2.646

2.  The effect of introducing IGRA to screen French healthcare workers for tuberculosis and potential conclusions for the work organisation.

Authors:  Adrien Moucaut; Albert Nienhaus; Benedicte Courtois; Virginie Nael; Claire Longuenesse; Bruno Ripault; Pierre Rucay; Stéphanie Moisan; Yves Roquelaure; Dominique Tripodi
Journal:  J Occup Med Toxicol       Date:  2013-05-07       Impact factor: 2.646

3.  Tuberculosis screening at the Sainte-Anne Hospital in Paris - results of first and second IGRA.

Authors:  Albert Nienhaus; Paul-Kenneth Gariepy; Catherine Trouve; Christiane Lhaumet; Jean Toureau; Claudia Peters
Journal:  J Occup Med Toxicol       Date:  2014-07-08       Impact factor: 2.646

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.